Nicholas C. Wrighton
Research Subjects
Nicholas C. Wrighton has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Arun K. Kashyap
University of California at Santa Cruz, Biology/Sinsheimer Lab., Santa Cruz
1 shared publicationFrancis P. Barbone
The R.W. Johnson Pharmaceutical Research Institute, Raritan
1 shared publicationFrancis X. Farrell
The R.W. Johnson Pharmaceutical Research Institute, Raritan
1 shared publicationLinda K. Jolliffe
The R.W. Johnson Pharmaceutical Research Institute, Raritan
1 shared publicationPalaniappan Balasubramanian
Affymax Research Institute, Palo Alto
1 shared publicationRonald W. Barrett
Affymax Research Institute, Palo Alto
1 shared publication
Latest Publications
- 1 November 1997
- Published by Springer Nature in Nature Biotechnology
- Vol. 15 (12) , 1261-1265
Increased potency of an erythropoietin peptide mimetic through covalent dimerization
We have synthesized a chemically defined, dimeric form of an erythropoietin mimetic peptide (EMP) that displays 100-fold increased affinity for the erythropoietin receptor (EPOR) and correspondingly elevated potency in cell-based assays and in mice. The dimeric EMP1 was synthesized using a C-terminal lysine residue as a branch point. A β-alanine residue was coupled to the main-chain (α) amino group of the lysine residue in order to provide a pseudosymmetrical scaffold where both the side-chain and main-chain were of approximately equal length. Using an orthogonal protection system, independently disulphide-cylized EMP1 moieties were synthesized upon this scaffold. The proposed mechanism of increased potency of the dimer over the parental compound EMP1 is consistent with the structure of a cocrystal of EMP1 and the extracellular domain of the EPOR in which a noncovalent peptide dimer is seen spanning the cleft between two molecules of the EPOR extracellular domain.
- 1 November 1997
- Published by Springer Nature in Nature Biotechnology
- Vol. 15 (12) , 1261-1265
Increased potency of an erythropoietin peptide mimetic through covalent dimerization
We have synthesized a chemically defined, dimeric form of an erythropoietin mimetic peptide (EMP) that displays 100-fold increased affinity for the erythropoietin receptor (EPOR) and correspondingly elevated potency in cell-based assays and in mice. The dimeric EMP1 was synthesized using a C-terminal lysine residue as a branch point. A β-alanine residue was coupled to the main-chain (α) amino group of the lysine residue in order to provide a pseudosymmetrical scaffold where both the side-chain and main-chain were of approximately equal length. Using an orthogonal protection system, independently disulphide-cylized EMP1 moieties were synthesized upon this scaffold. The proposed mechanism of increased potency of the dimer over the parental compound EMP1 is consistent with the structure of a cocrystal of EMP1 and the extracellular domain of the EPOR in which a noncovalent peptide dimer is seen spanning the cleft between two molecules of the EPOR extracellular domain.